MRK slides with Dow
Merck is trading down moderately in line with a broad S&P 500 and Dow sell-off, with its losses explicitly cited as a contributor to the Dow's drop, while pharma peers like ABBV face the same sector-wide selling pressure.
Sources: https://www.marketwatch.com/data-news/merck-3m-share-losses-contribute-to-dow-s-286-point-drop-d3bcb212-22244f352172
Sources
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works